United States· US:61703-319_3aa232be-a3c0-42d6-b959-c152c4136e65
Cytarabine
A cytarabine product containing cytarabine, registered in United States by Hospira, Inc.. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cytarabine is registered in 16 of 19 countries.
Countries holding a registration under ATC L01BC01 (cytarabine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Cytarabine · ATC L01BC01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CYTARABINE
- Manufacturer
- Hospira, Inc.
- Country
- United States (US)
- ATC code
- L01BC01
- ATC class
- Cytarabine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1161703-319-22
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
415 interactions on record for cytarabine.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cytarabine · interactions on record
415 records
- 35 severe
- 113 moderate
- 16 minor
- 251 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CladribineL01BB04severe
- PexidartinibL01EX15severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cytarabine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCytarabine 100mg/1ml solution for injection vialsPfizer Ltd
- BelgiumCytarabine Accord Healthcare 100 mg/mlAccord Healthcare
- FinlandArabineHospira Nordic AB
- CzechiaALEXANEBEWE Pharma Ges.m.b.H Nfg.KG, Unterach
- FranceARACYTINE 1 g, poudre pour solution pour perfusion (I.V.)PFIZER HOLDING FRANCE
- PolandAlexanEbewe Pharma Ges.m.b.H Nfg. KG
- SwedenCytarabin Fresenius Kabi 100 mg/ml Injektions-/infusionsvätska, lösningFresenius Kabi AB
- SpainCITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSIONAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Alexan, Cytarabin Accord
- Belgium · Cytarabine Accord Healthcare, Cytarabine Fresenius Kabi
- Bulgaria · Алексан, Цитарабин Акорд
- Cyprus · Cytarabine Accord, Cytarabine Pfizer Hellas
- Czechia · Alexan, Cytarabine Accord
- Germany · Ara-Cell, Cytarabin Accord
- Denmark · Cytarabin Fresenius Kabi, Cytarabine Accord
- Estonia · Cytarabine Accord, Cytarabine Kabi
- Spain · Citarabina Accord, Citarabina Kabi
- Finland · Cytarabine Accord, Cytarabine Accord Healthcare
- France · Aracytine, Cytarabine Accord
- United Kingdom (Northern Ireland) · Cytarabine Accord Healthcare, Cytarabine Fresenius Kabi Oncology
- Greece · Aracytin, Citabion
- Croatia · Cytosar
- Hungary · Alexan, Cytarabine Accord
- Ireland · Cytarabine, Cytarabine Accord Healthcare Ireland
- Iceland · Cytarabin Fresenius Kabi, Cytarabine Pfizer
- Italy · Aracytin, Citarabina Accord
- Lithuania · Cytarabine Accord, Cytarabine Kabi
- Luxembourg · Cytosar
- Latvia · Cytarabine Accord, Cytarabine Kabi
- Malta · Cytarabine Accord Healthcare, Cytarabine Pfizer Hellas
- Netherlands · Cytarabine Accord, Cytarabine Fresenius Kabi
- Norway · Cytarabin Fresenius Kabi, Cytarabine Accord
- Poland · Alexan, Cytarabina Accord
- Portugal · Citaloxan, Citarabina Accord
- Romania · Citarabină Accord, Citarabina Kabi
- Sweden · Cytarabin Fresenius Kabi, Cytarabin Hikma
- Slovenia · Citarabin Accord, Cytosar
- Slovakia · Cytarabine Accord, Cytosar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c7e824ba-0f50-4440-8f24-0b8e2aecd7cb GET /v1/drugs/c7e824ba-0f50-4440-8f24-0b8e2aecd7cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS",
"source": "ndc",
"strength": "100",
"substance": "CYTARABINE",
"productndc": "61703-319",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA075383",
"marketing_category": "ANDA"
}See everything about cytarabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.